Clinical Trial Update: Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II clinical trial is evaluating the safety and efficacy of IBI363 in combination with chemotherapy as second-line therapy for unresectable locally ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• IBI363

Snippet

Sponsor: Ruijin Hospital | Conditions: Pancreatic Cancer Metastatic | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING